Journal
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Volume 37, Issue 2, Pages 102-109Publisher
ELSEVIER
DOI: 10.1016/j.ijantimicag.2010.10.014
Keywords
Acinetobacter baumannii; Tigecycline; Peptides; Colistin; Rifampicin; Minocycline
Ask authors/readers for more resources
Multidrug-resistant Acinetobacter baumannii (MDR-AB) infections are difficult to treat owing to the extremely limited armamentarium. The present review reports all available treatment options against MDR-AB, including single molecules, combination schemes, and alternative modes of antimicrobial administration. Additionally, a group of recently reported peptides with anti-MDR-AB activity is described. (C) 2010 Elsevier B. V. and the International Society of Chemotherapy. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
